Information Journal Paper
APA:
Copy. (2019). SGLT2 inhibitors in patients with type 2 diabetes and renal disease: overview of current evidence. POSTGRADUATE MEDICINE, 131(4), 251-260. SID. https://sid.ir/paper/777317/en
Vancouver:
Copy. SGLT2 inhibitors in patients with type 2 diabetes and renal disease: overview of current evidence. POSTGRADUATE MEDICINE[Internet]. 2019;131(4):251-260. Available from: https://sid.ir/paper/777317/en
IEEE:
Copy, “SGLT2 inhibitors in patients with type 2 diabetes and renal disease: overview of current evidence,” POSTGRADUATE MEDICINE, vol. 131, no. 4, pp. 251–260, 2019, [Online]. Available: https://sid.ir/paper/777317/en